Dental Adverse Effects of Anti-CD20 Therapies

Dental Adverse Effects of Anti-CD20 Therapies

Abstract Introduction Over the past few years, anti-CD20 therapies like rituximab, ocrelizumab or ofatumumab have seen an increase in interest in the treatment of neurological autoimmune disorders such as multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), or resistant forms of...

Full description

Bibliographic Details
Main Authors: Hélène Bartak, Tasnim Fareh, Nouha Ben Othman, Delphine Viard, Mikael Cohen, Fanny Rocher, Elliot Ewig, Milou-Daniel Drici, Christine Lebrun-Frenay
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-04-01
Series:Neurology and Therapy
Subjects:
Multiple sclerosis
Anti-CD20
Ocrelizumab
Rituximab
Immunosuppressants
Dental and gingival conditions
Online Access:https://doi.org/10.1007/s40120-024-00616-7

Internet

https://doi.org/10.1007/s40120-024-00616-7

Similar Items